Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

May 17, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Appendicitis – Antibiotics or Appendectomy?

SIGN TO START PHASE 1 HUMAN TRIAL OF “ANTISERA”-DCGI

Can PRESENCEOF HYALURONAN be used as a treatment option in COVID19 patients?

Appendicitis – Antibiotics or Appendectomy?
  • BiotechToday
  • World

Appendicitis – Antibiotics or Appendectomy?

bioxone October 7, 2020October 7, 2020

Thota Kanishka Rao, Amity University Kolkata

Appendectomy has for quite some time been the standard treatment for appendicitis, even though effective utilisation of anti-microbial therapy as an option was accounted for over 60 years. Even in recent years, more than 95% of U.S. patients with appendicitis underwent an appendectomy.

However, with the ongoing Covid-19 pandemic, health systems, for example, the American College of Surgeons10 have suggested reevaluation of numerous aspects of care conveyance, remembering the function of antibiotics for the therapy of appendicitis. Researchers conducted the Comparison of Outcomes of Antibiotic Drugs and Appendectomy (CODA) trial to compare antibiotic therapy with appendectomy in adults with appendicitis, including those with an appendicolith.

The trial design depended on the recognition that not all patients prioritise the various results identified with appendicitis care similarly. An overall measure of health status was utilised for the primary outcome, and analysis of several secondary clinical and patient-reported results, complications, and time spent in health care settings were performed. A pragmatic, nonblinded, noninferiority, randomised trial comparing antibiotic therapy (10-day course) with appendectomy in patients with appendicitis at 25 U.S. centres. 

The primary result was 30-day health status, as surveyed with the European Quality of Life–5 Dimensions (EQ-5D) poll (scores run from 0 to 1, with higher scores demonstrating better health status; noninferiority edge, 0.05 points). Secondary results included appendectomy for the antibiotics agents’ group and complications through 90 days; analyses were prespecified in subgroups characterised by the presence or absence of an appendicolith.

Antibiotics were non-inferior to appendectomy based on 30-day EQ-5D scores (mean difference, 0.01 points; 95% confidence interval [CI], −0.001 to 0.03). 

Antibiotic agents were non-inferior to appendectomy based on 30-day EQ-5D scores (mean contrast, 0.01 points; 95% confidence interval [CI], −0.001 to 0.03). In the antibiotics group, 29% had gone through appendectomy by 90 days, incorporating 41% of those with an appendicolith and 25% of those without an appendicolith.

Also read: Complement Tissue injury and its protection during COVID-19

Source:

A Randomized Trial Comparing Antibiotics with Appendectomy for Appendicitis: NEJM New England Journal of Medicine. Author affiliations of the members of the writing committee are as follows: the University of Washington (D.R.F., & Jacobs https://www.nejm.org/doi/full/10.1056/NEJMoa2014320

  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Related

Tagged antibiotics antimicrobial therapy appendectomy Appendicitis appendicitis treatment appendicolith appendix clinical research CODA COVID-19 Drug Research European Quality of Life–5 Dimensions (EQ-5D) poll Survey US Patent

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

Can PRESENCEOF HYALURONAN be used as a treatment option in COVID19 patients?

bioxone October 7, 2020

Arpita Adhikary, Amity University Kolkata Deterioration of the respiratory system mainly the lungs is prominent in SARS COVID-19. An active agent, a jelly-like substance was found in dead COVID 19 patients’ respiratory system.  A novel fact is established by the researchers as they conducted an experiment comparing the diseased lung tissue of COVID patients and […]

HYALURONAN

Related Post

  • BiotechToday
  • World

The Function of ABCG2 in hyperuricemia and gout

bioxone June 24, 2021June 23, 2021

Madhavi Bhatia,NIPER Guwahati Hyperuricemia is a condition with increased uric acid levels in the blood which results in the deposition of monosodium urate crystals in synovial fluid of joints resulting in gout. Increased levels may be caused due to increased hepatic biosynthesis or reduced renal or intestinal excretion of urate. Most of the urate is […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • BiotechToday
  • World

A Study on Cardiac Sequelae After COVID-19 Recovery

BioTech Today July 15, 2021July 14, 2021

Srabani Roy Chowdhury, MAKAUT- West Bengal We all know that COVID-19 principally affects the respiratory system. But recent reports state that both SARS-CoV-2 recovered and active patients show extra-pulmonary manifestations, which can be cardiovascular, renal, gastrointestinal and, neurological. The interaction between SARS-CoV-2 with the cardiovascular system is not much recognized yet. But studies show that […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • BiotechToday
  • World

A new strategy for Covid: Targeting TMPRSS2 and ACE2 (Androgenic Regulations)

bioxone October 20, 2020October 20, 2020

Anwesha Chatterjee, Amity University Kolkata The novel Corona Virus (SARS-CoV-2) infection which is responsible for the COVID-19 pandemic is expecting an adverse effect on the progression of multiple cancers, i.e. prostate cancer, due to the transpiring cytokine storm associated with oncogenic signalling. Cancer progression can be prevented at an early stage by blocking SARS-COV-2 infection […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy